ClinicalTrials.gg
Active, not recruitingNCT05005117Updated Apr 22, 2026

Laparoscopic Approach for Emergency Colon Resection

An interventional study of Laparoscopic operation and Open operation in Laparoscopic Surgery, Colorectal Cancer and Colorectal Disorders, sponsored by Joint Authority for Päijät-Häme Social and Health Care. Active, not recruiting at 1 site in Finland. Open to participants aged 18 Years to 100 Years. Per ClinicalTrials.gov, last updated 2026-04-22.

Sponsored by Joint Authority for Päijät-Häme Social and Health Care · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
192
Allocation
Randomized
Ages
18 Years to 100 Years
Sex
All
01

Study summary

This is a randomized, controlled, parallel, multicenter trial to compare post-operative complications and long-term results between open and laparoscopic technique in emergency colorectal surgery.

Read the detailed description

Laparoscopic technique in elective colorectal surgery has been shown to be advantageous for patients compared to open technique. However, the feasibility and potential benefits of laparoscopic colorectal surgery in emergency setting has not been evaluated sufficiently.

The aim of this study is to compare laparoscopic and open technique in emergency colon resections. Primary outcome is the immediate recovery after operation and secondary outcome is long-term overall and cancer-specific survival.

02

Conditions studied

  • Laparoscopic Surgery
  • Colorectal Cancer
  • Colorectal Disorders
  • Emergencies
  • Complication of Surgical Procedure
  • Long-term Effects of Cancer Treatment

Keywords

  • Laparoscopic surgery
  • Emergency surgery
  • Colorectal
03

In context

Colorectal Neoplasms

6,541 studies on the registry are indexed under Colorectal Neoplasms; 1,667 are open to participants now.

This study's planned enrollment of 192 is above the median of 76 across 4,800 interventional studies indexed under Colorectal Neoplasms.

Browse Colorectal Neoplasms studies →

Lead sponsor

Joint Authority for Päijät-Häme Social and Health Care is the lead sponsor of 19 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 100 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • all patients in need of emergency colon resection

Exclusion criteria

Exclusion Criteria:

  • age \< 18 year
  • trauma patients
  • reoperations
  • acute pancreatitis
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
192 participants (estimated)

Study arms

  • Experimental
    Laparoscopic operation

    Laparoscopic emergency colon resection

    Procedure: Laparoscopic operation

  • Active comparator
    Open operation

    Open emergency colon resection

    Procedure: Open operation

Interventions

  • ProcedureLaparoscopic operation

    Operation

  • ProcedureOpen operation

    Operation

06

What researchers measure

Primary outcomes

  1. postoperative morbidity

    Postoperative morbidity evaluated by Clavien-Dindo classification

    Time frame: 30 days

Secondary outcomes

  1. Surgical site infections

    Surgical site infections, superficial and deep

    Time frame: 30 days

  2. Long-term Survival

    Long-term overall and cancer-specific survival

    Time frame: 5 years

07

Study locations

1 site
  • Marie Grönroos-Korhonen
    Lahti, 15850, Finland
08

References and documents

Publications

  • Gronroos-Korhonen MT, Kossi JAO. LapEmerge trial: study protocol for a laparoscopic approach for emergency colon resection-a multicenter, open label, randomized controlled trial. Trials. 2024 Apr 17;25(1):268. doi: 10.1186/s13063-024-08058-0. PubMed 38632602 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 22, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05005117
Lead sponsor
Joint Authority for Päijät-Häme Social and Health Care
Collaborators
Kanta-Häme Central Hospital
Responsible party
Sponsor
First posted
Aug 13, 2021
Start date
Sep 17, 2021
Primary completion
Jul 30, 2031 (estimated)
Completion
Jul 30, 2031 (estimated)
Last update
Apr 22, 2026

Study contacts

Marie T Grönroos-Korhonen, MD
principal investigator · Päijät Häme Central Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Feb 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion